Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115188) titled 'Moxibustion alleviated Irritable bowel syndrome by modulating gut microbiota composition and metabolic profiles' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Condition:
IBS
Intervention:
Control group:Simulated Moxibustion
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-06-07
Target Sample Size: Control group:30;Intervention group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=294915
Published by HT...